Observational studyAllergy2026

Patient-Perceived Benefits of Named-Patient Product Sublingual Immunotherapy in Allergic Rhinitis and Asthma: Primary Results From the ERAPP Real-World Cohort Study.

Davide Caimmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.